Oral L-carnitine and Inflammatory and Nutritional Biomarkers in Maintenance Hemodialysis
NCT07249229
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
End-stage Renal Disease (ESRD)
Hemodialysis
Interventions
DRUG:
L-carnitine 1000 Mg
DRUG:
Placebo
Sponsor
Darya Chamani